SRPT, 3/5-4/15, -2% Loss

4月17日

I’m n 2/28/2024, Sarepta Therapeutics (SRPT) reported earnings of $0.51 per share on revenue of $396.78 million for the fourth quarter ended December 2023. The consensus earnings estimate was $0.01 per share on revenue of $384.54 million.